US Stock MarketDetailed Quotes

BioNexus Gene Lab (BGLC)

Watchlist
  • 1.975
  • 0.0000.00%
Trading May 13 16:00 ET
4.77MMarket Cap-1.23P/E (TTM)

BioNexus Gene Lab (BGLC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-21.93%7.42M
-80.83%483.76K
-3.29%2.54M
14.47%2.26M
-10.28%2.14M
-2.66%9.51M
11.03%2.52M
3.00%2.63M
-23.07%1.97M
0.20%2.38M
Operating revenue
-21.93%7.42M
-80.83%483.76K
-3.29%2.54M
14.47%2.26M
-10.28%2.14M
-2.66%9.51M
11.03%2.52M
3.00%2.63M
-23.07%1.97M
0.20%2.38M
Cost of revenue
-22.89%6.34M
-77.98%487.74K
-5.98%2.17M
12.24%1.89M
-11.07%1.79M
-2.61%8.22M
10.37%2.21M
4.75%2.3M
-24.30%1.69M
0.42%2.02M
Gross profit
-15.84%1.09M
-101.29%-3.98K
15.66%377.69K
27.47%368.02K
-5.90%343.49K
-3.01%1.29M
16.01%309.23K
-7.84%326.54K
-15.01%288.72K
-1.05%365.03K
Operating expense
30.72%4.24M
40.27%1.03M
-33.73%1.19M
607.96%1.07M
68.41%959.68K
-26.37%3.25M
48.10%732.87K
-37.81%1.79M
-75.35%150.86K
35.83%569.86K
Selling and administrative expenses
1.55%4.07M
26.16%1.01M
-51.06%997.26K
61.83%1.13M
98.56%932.57K
31.74%4M
157.83%801.8K
-33.88%2.04M
-13.85%695.32K
-12.52%469.67K
-Selling and marketing expense
-14.50%1.74M
-92.80%35.64K
-55.71%551.57K
345.75%608.43K
251.39%540.7K
240.23%2.03M
--494.86K
--1.25M
--136.49K
--153.87K
-General and administrative expense
18.05%2.33M
217.94%975.87K
-43.76%445.69K
-7.52%516.79K
24.09%391.88K
-19.19%1.97M
115.48%306.93K
-74.29%792.41K
-30.76%558.83K
-41.18%315.79K
Research and development costs
6.65%50.67K
-36.20%11.1K
42.46%14.88K
53.17%12.56K
5.79%12.14K
-13.59%47.51K
--17.4K
--10.44K
--8.2K
--11.48K
Provision for doubtful accounts
115.69%126.44K
106.27%5.41K
168.78%175.82K
87.38%-69.76K
-83.12%14.97K
-161.31%-805.88K
---86.32K
---255.61K
---552.66K
--88.72K
Other operating expenses
----
----
----
----
----
----
----
-133.60%-465.53K
-274.10%-730.11K
-72.01%-201.85K
Operating profit
-61.41%-3.16M
-143.61%-1.03M
44.74%-810.27K
-607.75%-699.99K
-200.83%-616.19K
36.46%-1.96M
-85.58%-423.64K
42.01%-1.47M
150.65%137.86K
-304.55%-204.83K
Net non-operating interest income expense
-49.13%64.35K
-76.85%6.5K
-50.41%14.3K
-45.01%24.89K
-23.28%18.66K
131.06%126.5K
-56.45%28.09K
776.90%28.83K
1,587.80%45.26K
1,094.76%24.32K
Non-operating interest income
-43.18%83.89K
-71.17%9.77K
-40.67%20.78K
-40.15%29.77K
-18.68%23.57K
114.99%147.64K
--33.9K
--35.02K
--49.74K
--28.98K
Non-operating interest expense
-7.59%19.54K
-43.70%3.27K
4.67%6.48K
8.91%4.88K
5.32%4.91K
51.81%21.15K
38.94%5.81K
45.41%6.19K
47.27%4.48K
90.63%4.66K
Other net income (expense)
-53.49%109.5K
59.90%-10.62K
-6.99%86.98K
-17.65%58.93K
-126.65%-25.8K
-43.59%235.42K
-26.48K
93.52K
71.57K
96.82K
Gain on sale of security
-71.59%50.01K
337.87%77.13K
-7.59%46.57K
-135.57%-18.63K
-198.98%-55.05K
-53.10%176.02K
--17.61K
--50.39K
--52.39K
--55.62K
Earnings from equity interest
----
----
----
9.15%-51K
-54.63%-68.5K
----
----
----
---56.14K
---44.3K
Other non- operating income (expenses)
0.13%59.49K
-98.99%-87.75K
-6.29%40.41K
304.56%77.57K
-29.00%29.25K
41.13%59.41K
---44.1K
--43.13K
--19.17K
--41.2K
Income before tax
-87.14%-2.98M
-145.51%-1.04M
47.24%-708.99K
-341.93%-616.17K
-644.81%-623.33K
38.84%-1.59M
-266.44%-422.03K
46.94%-1.34M
192.53%254.69K
-57.68%-83.69K
Income tax
0
0
0
0
0
-83.77%3.49K
-34.29%-73.71K
-97.97%1.56K
447.62%55.58K
25.50%20.07K
Net income
-86.73%-2.98M
-197.46%-1.04M
47.30%-708.99K
-409.47%-616.17K
-500.76%-623.33K
39.20%-1.6M
-212.92%-348.32K
48.44%-1.35M
176.80%199.1K
-50.23%-103.76K
Net income continuous Operations
-86.73%-2.98M
-197.46%-1.04M
47.30%-708.99K
-409.47%-616.17K
-500.76%-623.33K
39.20%-1.6M
-212.92%-348.32K
48.44%-1.35M
176.80%199.1K
-50.23%-103.76K
Minority interest income
Net income attributable to the parent company
-86.73%-2.98M
-197.46%-1.04M
47.30%-708.99K
-409.47%-616.17K
-500.76%-623.33K
39.20%-1.6M
-212.92%-348.32K
48.44%-1.35M
176.80%199.1K
-50.23%-103.76K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-86.73%-2.98M
-197.46%-1.04M
47.30%-708.99K
-409.47%-616.17K
-500.76%-623.33K
39.20%-1.6M
-212.92%-348.32K
48.44%-1.35M
176.80%199.1K
-50.23%-103.76K
Basic earnings per share
-79.15%-1.607
-170.47%-0.522
47.26%-0.395
-403.54%-0.343
-483.33%-0.35
45.96%-0.897
-172.52%-0.193
51.85%-0.749
163.10%0.113
14.29%-0.06
Diluted earnings per share
-79.15%-1.607
-170.47%-0.522
47.26%-0.395
-403.54%-0.343
-483.33%-0.35
45.96%-0.897
-210.54%-0.193
51.85%-0.749
163.10%0.113
14.29%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -21.93%7.42M-80.83%483.76K-3.29%2.54M14.47%2.26M-10.28%2.14M-2.66%9.51M11.03%2.52M3.00%2.63M-23.07%1.97M0.20%2.38M
Operating revenue -21.93%7.42M-80.83%483.76K-3.29%2.54M14.47%2.26M-10.28%2.14M-2.66%9.51M11.03%2.52M3.00%2.63M-23.07%1.97M0.20%2.38M
Cost of revenue -22.89%6.34M-77.98%487.74K-5.98%2.17M12.24%1.89M-11.07%1.79M-2.61%8.22M10.37%2.21M4.75%2.3M-24.30%1.69M0.42%2.02M
Gross profit -15.84%1.09M-101.29%-3.98K15.66%377.69K27.47%368.02K-5.90%343.49K-3.01%1.29M16.01%309.23K-7.84%326.54K-15.01%288.72K-1.05%365.03K
Operating expense 30.72%4.24M40.27%1.03M-33.73%1.19M607.96%1.07M68.41%959.68K-26.37%3.25M48.10%732.87K-37.81%1.79M-75.35%150.86K35.83%569.86K
Selling and administrative expenses 1.55%4.07M26.16%1.01M-51.06%997.26K61.83%1.13M98.56%932.57K31.74%4M157.83%801.8K-33.88%2.04M-13.85%695.32K-12.52%469.67K
-Selling and marketing expense -14.50%1.74M-92.80%35.64K-55.71%551.57K345.75%608.43K251.39%540.7K240.23%2.03M--494.86K--1.25M--136.49K--153.87K
-General and administrative expense 18.05%2.33M217.94%975.87K-43.76%445.69K-7.52%516.79K24.09%391.88K-19.19%1.97M115.48%306.93K-74.29%792.41K-30.76%558.83K-41.18%315.79K
Research and development costs 6.65%50.67K-36.20%11.1K42.46%14.88K53.17%12.56K5.79%12.14K-13.59%47.51K--17.4K--10.44K--8.2K--11.48K
Provision for doubtful accounts 115.69%126.44K106.27%5.41K168.78%175.82K87.38%-69.76K-83.12%14.97K-161.31%-805.88K---86.32K---255.61K---552.66K--88.72K
Other operating expenses -----------------------------133.60%-465.53K-274.10%-730.11K-72.01%-201.85K
Operating profit -61.41%-3.16M-143.61%-1.03M44.74%-810.27K-607.75%-699.99K-200.83%-616.19K36.46%-1.96M-85.58%-423.64K42.01%-1.47M150.65%137.86K-304.55%-204.83K
Net non-operating interest income expense -49.13%64.35K-76.85%6.5K-50.41%14.3K-45.01%24.89K-23.28%18.66K131.06%126.5K-56.45%28.09K776.90%28.83K1,587.80%45.26K1,094.76%24.32K
Non-operating interest income -43.18%83.89K-71.17%9.77K-40.67%20.78K-40.15%29.77K-18.68%23.57K114.99%147.64K--33.9K--35.02K--49.74K--28.98K
Non-operating interest expense -7.59%19.54K-43.70%3.27K4.67%6.48K8.91%4.88K5.32%4.91K51.81%21.15K38.94%5.81K45.41%6.19K47.27%4.48K90.63%4.66K
Other net income (expense) -53.49%109.5K59.90%-10.62K-6.99%86.98K-17.65%58.93K-126.65%-25.8K-43.59%235.42K-26.48K93.52K71.57K96.82K
Gain on sale of security -71.59%50.01K337.87%77.13K-7.59%46.57K-135.57%-18.63K-198.98%-55.05K-53.10%176.02K--17.61K--50.39K--52.39K--55.62K
Earnings from equity interest ------------9.15%-51K-54.63%-68.5K---------------56.14K---44.3K
Other non- operating income (expenses) 0.13%59.49K-98.99%-87.75K-6.29%40.41K304.56%77.57K-29.00%29.25K41.13%59.41K---44.1K--43.13K--19.17K--41.2K
Income before tax -87.14%-2.98M-145.51%-1.04M47.24%-708.99K-341.93%-616.17K-644.81%-623.33K38.84%-1.59M-266.44%-422.03K46.94%-1.34M192.53%254.69K-57.68%-83.69K
Income tax 00000-83.77%3.49K-34.29%-73.71K-97.97%1.56K447.62%55.58K25.50%20.07K
Net income -86.73%-2.98M-197.46%-1.04M47.30%-708.99K-409.47%-616.17K-500.76%-623.33K39.20%-1.6M-212.92%-348.32K48.44%-1.35M176.80%199.1K-50.23%-103.76K
Net income continuous Operations -86.73%-2.98M-197.46%-1.04M47.30%-708.99K-409.47%-616.17K-500.76%-623.33K39.20%-1.6M-212.92%-348.32K48.44%-1.35M176.80%199.1K-50.23%-103.76K
Minority interest income
Net income attributable to the parent company -86.73%-2.98M-197.46%-1.04M47.30%-708.99K-409.47%-616.17K-500.76%-623.33K39.20%-1.6M-212.92%-348.32K48.44%-1.35M176.80%199.1K-50.23%-103.76K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -86.73%-2.98M-197.46%-1.04M47.30%-708.99K-409.47%-616.17K-500.76%-623.33K39.20%-1.6M-212.92%-348.32K48.44%-1.35M176.80%199.1K-50.23%-103.76K
Basic earnings per share -79.15%-1.607-170.47%-0.52247.26%-0.395-403.54%-0.343-483.33%-0.3545.96%-0.897-172.52%-0.19351.85%-0.749163.10%0.11314.29%-0.06
Diluted earnings per share -79.15%-1.607-170.47%-0.52247.26%-0.395-403.54%-0.343-483.33%-0.3545.96%-0.897-210.54%-0.19351.85%-0.749163.10%0.11314.29%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More